10.2 Performing the DLCO Maneuver

From selected protocol to performed maneuver (II.B.9)

Domain II.B Perform task II.B.9 is where DLCO is won or lost in real time. The circuit may be correct and pre-test smoking documented, yet a weak inspiration, 6-second hold, leaky seal, or contaminated alveolar sample will destroy DLCO and VA. This section is the hands-on performance layer aligned with ATS/ERS single-breath DLCO technical standards concepts used in modern PFT labs and NBRC-style stems.

Goals of a well-performed DLCO-SB trial:

1. Inspired volume near the patient’s vital capacity (formal VI/VC criteria in 10.3).
2. Rapid inspiration of test gas (minimize transit time that blurs “time zero”).
3. Stable breath-hold near target duration without strain (Valsalva) or suck (Müller).
4. Washout that clears dead space before the alveolar sample.
5. Alveolar sample that represents mixed alveolar gas for CO and tracer analysis.
6. Patient recovery and safe total CO load across the session.

Step-by-step single-breath sequence

Explain the entire maneuver before the mouthpiece is busy. Patients who only hear “hold your breath” often fail inspiration or seal.

1. Positioning and interface

• Seated upright, feet supported, nose clip on, tight lip seal on filter/mouthpiece.
• Hands relaxed; support the circuit so the patient is not fighting tubing weight.
• Demonstrate: “Blow out gently all the way, then blast the gas in fast until you’re full, hold still with an open throat, then blow out when I say.”

2. Tidal breathing

• Several quiet tidal breaths on the mouthpiece establish a stable seal and calm the patient.
• Watch for leaks (flow baseline, patient report of air at the nose/lips).
• Do not start the forced RV exhalation while the patient is still laughing, coughing, or talking.

3. Unforced exhalation toward residual volume (RV)

• Coach a relaxed, complete exhalation—not a forced spirometry blast.
• Purpose: start the inspiratory vital capacity from a low lung volume so the inspired test-gas volume can approach VC and fill the lungs.
• Incomplete exhalation before inspiration reduces the achievable inspired volume relative to true VC and is a common performance failure.

Coaching language: “Blow out slowly… keep going… empty… empty… now get ready to fill fast.”

4. Rapid inspiration of test gas to TLC

• On cue, the valve delivers test gas; the patient inspires rapidly and fully to total lung capacity.
• Encourage continuous inspiration without mid-breath pauses that create a stepwise VI.
• Watch the volume display: stop coaching “more, more” only when a true plateau at TLC is reached or the patient cannot inspire further safely.
• Inspiration that is too slow prolongs the “effective” breath-hold timing uncertainty; standards emphasize a brisk inspiratory vital capacity.

Coaching language: “Gas on—fill fast! Deep… deeper… full lungs—hold!”

5. Breath-hold (~10 seconds)

• Target breath-hold time is about 10 seconds, with acceptability commonly discussed as roughly 8–12 seconds (10 ± 2 s concept) for standard grading—details in 10.3.
• Patient should hold with open glottis, relaxed chest, no straining against a closed throat.
• Valsalva (expiratory effort against closed glottis) reduces pulmonary capillary blood volume → can lower DLCO.
• Müller (inspiratory effort against closed glottis) increases capillary blood volume → can raise DLCO.
• Count calmly: “Hold 2… 3… 4…” Maintain eye contact; a panicked swallow or lip leak mid-hold ruins the trial.

6. Rapid exhalation, washout, and alveolar sample

• On cue, patient exhales smoothly and promptly (not a weak dribble that fails to clear dead space, and not an uncontrolled cough).
• System discards washout volume (dead-space clearance—classically on the order of 0.75–1.0 L in adults, with reduced washout when VC is small per standards/manufacturer rules).
• Then collects an alveolar sample (often about 0.5–1.0 L depending on system and VC) for CO and tracer analysis.
• Patient must not inspire during sample collection; a nested breath contaminates the sample with fresh gas or room air.

After the sample: come off the mouthpiece, remove nose clip if needed, and recover with normal breathing.

Maneuver map (exam-ready)

Coaching tips that separate pass from fail

Before the first scored trial

• Demo with hand motions: empty → fill fast → freeze → blow out.
• Allow one practice with air (if system permits) for coordination without CO exposure when helpful.
• Warn about the taste/dryness of test gas so the patient does not break seal in surprise.

During the hold

• “Keep lips tight—soft belly—don’t push and don’t suck.”
• If cheeks puff hard with strain, stop and reteach open-glottis hold on the next trial.
• If the patient talks or laughs on the mouthpiece, abort and restart after recovery.

After each trial—specific feedback

Give one primary cue per repeat. Overloading with five criticisms at once reduces the next effort.

Number of trials and recovery between trials

How many trials?

• Aim for at least two acceptable maneuvers that meet validity and repeatability (10.3) so a reportable mean (or standards-aligned average of acceptable efforts) can be issued.
• Additional trials are performed when the first efforts fail inspiration, timing, leak, or sample criteria—not indefinitely for cosmetic improvement once two excellent matching trials exist.
• Practical sessions often use several attempts; know your lab’s ceiling (see CO exposure below).

Recovery interval

• ATS/ERS-aligned practice spaces trials by about ≥4 minutes between single-breath maneuvers.
• Reasons: allow elimination of residual test gas, stabilize alveolar gas composition, reduce COHb rise between trials, and let the patient recover from deep inspiration/breath-hold.
• Shorter intervals can bias subsequent DLCO and VA; stems that describe “immediate back-to-back DLCO without rest” flag a performance error.

Session workflow

1. Confirm pre-test status and equipment (10.1).
2. Instruct and demonstrate.
3. Perform trial 1 → review VI, BHT, sample flags → feedback.
4. Wait ≥4 minutes (timer, not guesswork).
5. Trial 2 → compare to trial 1 for repeatability trajectory.
6. Add trials only as needed for two acceptable matching results or until safety/max-trial limits.
7. Document Hb pathway and any smoking/O₂ notes for the report.

Safety: CO exposure limits and maximum trials

Each DLCO trial delivers a small CO load. Healthy labs treat cumulative exposure seriously:

• COHb increases with repeated trials; elevated COHb reduces subsequent DLCO and is undesirable for the patient.
• Technical standards and lab policy set a practical maximum number of maneuvers per session (commonly discussed around five trials as a planning ceiling—know local SOP; exam items test the concept of a limit, not a license to ignore policy).
• Do not “chase” a third decimal place of agreement with endless CO inhalations after two acceptable, repeatable trials.
• Abort the session for chest pain, syncope, severe distress, or inability to seal safely—document partial data rather than forcing heroic holds.
• Pregnant patients and other special populations follow medical-director rules; CO exposure remains a reason for judicious trial counts.

Exam trap: “Unlimited DLCO trials are fine because CO fraction is only 0.3%.” Dilute is not zero risk across many repeats; performance includes stewardship of trial number.

Related safety during the maneuver

• Monitor for dizziness after long holds; allow seated recovery.
• Patients with severe obstruction may struggle with full inspiration—coach without hypoxemic crisis; continuous oximetry per lab policy for fragile patients.
• Never leave a patient locked on a demand valve without a clear way to get room air if panic occurs—know emergency valve/release procedures for your device.

Special populations: performance adjustments (same physiology)

Reduced VC / frail / elderly

• More practice of the empty–fill–hold sequence off gas when possible.
• Expect more rest; still require near-maximal inspiration relative to that patient’s VC for validity.
• Use reduced washout algorithms when VC is small (system/settings selection from 10.1, execution here).

Anxious patients

• Shorten verbal load; count breath-hold with them.
• One successful full practice of timing often beats three panicked gas trials.

Language barriers

• Interpreter + demonstration; visual countdown timer for the hold.

What “good performance” looks like on the display

• Inspired volume trace rises steeply to a clear TLC plateau.
• Breath-hold segment flat (no leak flow, no mid-hold inspiration).
• Exhalation promptly clears washout; sample window marked in alveolar gas without rebreathing artifact.
• Computed DLCO and VA stable across good trials within repeatability (graded in 10.3).

RPFT performance vignettes

Vignette 1: Patient inspires only 2.0 L though FVC is 3.8 L, holds 10 s perfectly. Action: reteach complete exhalation to RV and full TLC inspiration—do not accept “pretty timing” with inadequate VI.

Vignette 2: Patient bears down during hold; face reddens; DLCO is much lower than prior visits. Action: identify likely Valsalva; reteach relaxed hold; repeat after recovery—do not report strained trial as new disease without technical note.

Vignette 3: Two trials done 45 seconds apart “to finish before lunch.” Action: performance violation of recovery interval; wait appropriate time; recognize possible COHb/residual gas bias.

Vignette 4: Six failed attempts already; patient tired; CO trials accumulating. Action: stop at policy max; document inability or limited study; do not continue indefinitely.

Link forward

Performance produces candidate maneuvers; Domain II.C.9 decides which are acceptable, whether DLCO is repeatable, and which technical failures (leak, Valsalva/Müller, incomplete inspiration, sample errors) require rejection (section 10.3). Interpretation adjustments such as Hb and COHb effects on the reported number continue into data management domains—but validity starts with the maneuvers you accept here.